Access Bio Inc (950130) — Free Cash Flow Generation Index

Latest as of March 2025: 1292.47x

Access Bio Inc (950130) has a Free Cash Flow Generation Index of 1292.47x as of March 2025. Free cash flow of ₩6.92 Billion represents 1292% of operating cash flow (₩5.35 Million). See 950130 working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1292.47x
Free Cash Flow / Operating CF

Free Cash Flow

₩6.92 Billion
KRW

Operating Cash Flow

₩5.35 Million
KRW

Capital Expenditures

₩635.11K
KRW

Access Bio Inc Free Cash Flow Generation Index (2012–2024)

Historical FCF Generation Index trend for Access Bio Inc across 8 annual periods. Explore 950130 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Access Bio Inc (2012–2024)

Year-by-year Free Cash Flow Generation Index for Access Bio Inc. For the full company profile including market capitalisation, see Access Bio Inc market capitalisation.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2024 1318.33x ₩17.85 Billion ₩13.54 Million ₩1.40 Million ▲ +9.6%
2022 1202.40x ₩350.29 Billion ₩291.33 Million ₩14.90 Million ▲ +28.2%
2021 938.15x ₩129.37 Billion ₩137.90 Million ₩28.76 Million ▲ +132172.7%
2020 0.71x ₩26.05 Billion ₩36.72 Billion ₩10.38 Billion ▼ -87.7%
2016 5.74x ₩12.14 Million ₩2.11 Million ₩10.03 Million ▲ +113.3%
2015 2.69x ₩7.72 Billion ₩2.87 Billion ₩4.85 Billion ▲ +1.3%
2013 2.66x ₩4.22 Billion ₩1.59 Billion ₩2.63 Billion ▲ +55.7%
2012 1.71x ₩3.15 Billion ₩1.85 Billion ₩1.31 Billion
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).